RGLS

Regulus Therapeutics
RGLS

Overview Fund Activity
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

37 hedge funds and large institutions have $35.1M invested in Regulus Therapeutics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 14 closing their positions.

Holders
37
Holders Change
-10
Holders Change %
-21.28%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
11
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$118K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$58K
3
WS
3
Wedbush Securities
California
$31K
4
PAM
4
Panagora Asset Management
Massachusetts
$25K
5
MOS
5
MGO One Seven
Ohio
$4K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$783K
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
CS
3
Candriam SCA
Luxembourg
$0
4
SDIC
4
South Dakota Investment Council
South Dakota
$73K
5
DS
5
DRW Securities
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Wolverine Trading
51
Wolverine Trading
Illinois
– – – –
Morgan Stanley
52
Morgan Stanley
New York
$0 1,834 +9 +0.5%
NFG
53
Next Financial Group
Texas
$0 600 +600 New
1 2
3